Diabetes as a Risk Factor for Medication-Related Osteonecrosis of the Jaw
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes as a Risk Factor for Medication-Related Osteonecrosis of the Jaw
Authors
Keywords
-
Journal
JOURNAL OF DENTAL RESEARCH
Volume 94, Issue 2, Pages 252-260
Publisher
SAGE Publications
Online
2014-12-05
DOI
10.1177/0022034514560768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress in bisphosphonate-related osteonecrosis of the jaws
- (2014) Jose Bagan et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Morphological changes induced by advanced glycation endproducts in osteoblastic cells: Effects of co-incubation with alendronate
- (2013) María Virginia Gangoiti et al. ACTA HISTOCHEMICA
- Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
- (2013) Shirin Kalyan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: A study in Wistar rats
- (2013) Soraya A. Berti-Couto et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- The effect of bisphosphonate therapy on neutrophil function: a potential biomarker
- (2013) C.L. Favot et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Diabetes Microvascular Disease and the Risk for bisphosphonate-related Osteonecrosis of the Jaw: A Single Center Study
- (2013) Shira Molcho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of stem cell factor and high-sensitivity C reactive protein concentrations in crevicular fluid and serum in patients with chronic periodontitis with and without type 2 diabetes
- (2013) Nitish Kalra et al. Journal of Oral Science
- Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel
- (2012) Hideyo Miyazaki et al. BJU INTERNATIONAL
- Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid
- (2012) Marco Mozzati et al. Clinical Oral Investigations
- Gingival vascular functions are altered in type 2 diabetes mellitus model and/or periodontitis model
- (2012) Shuta Sugiyama et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws
- (2012) MS. Bocanegra-Perez et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Intravenous bisphosphonate–related osteonecrosis of the jaw: Long-term follow-up of 109 patients
- (2012) Amber L. Watters et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Zoledronate and pamidronate depress neutrophil functions and survival in mice
- (2011) JWP Kuiper et al. BRITISH JOURNAL OF PHARMACOLOGY
- Bisphosphonates Inhibit Expression of p63 by Oral Keratinocytes
- (2011) E.L. Scheller et al. JOURNAL OF DENTAL RESEARCH
- Risk Factors for Osteonecrosis of the Jaws
- (2011) A. Barasch et al. JOURNAL OF DENTAL RESEARCH
- Bisphosphonates Induce Apoptosis of Circulating Endothelial Cells in Multiple Myeloma Patients and in Subjects with Bisphosphonate-Induced Osteonecrosis of the Jaws
- (2010) Alessandro Allegra et al. ACTA HAEMATOLOGICA
- Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
- (2010) Valentina Guarneri et al. BREAST CANCER RESEARCH AND TREATMENT
- Antibody to Receptor Activator of NF-κB Ligand Ameliorates T Cell-Mediated Periodontal Bone Resorption
- (2010) Xiaoping Lin et al. INFECTION AND IMMUNITY
- Inhibition of antigen-presenting cell function by alendronate in vitro
- (2010) Paolo Sansoni et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice
- (2010) Takashi Kikuiri et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus
- (2010) I. Kanazawa et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of bisphosphonate osteonecrosis (BON) in cancer
- (2010) Cesar Augusto Migliorati et al. SUPPORTIVE CARE IN CANCER
- The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone MetabolismIn Vitro
- (2009) Eugen Muschler et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?
- (2009) Philippe Lesclous et al. BONE
- Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents
- (2009) Jeanny B. Aragon-Ching et al. CANCER INVESTIGATION
- PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells
- (2009) Keith R. Shockley et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
- (2009) Matthew R. Allen et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Vascular Endothelial Growth Factor and Microvessel Density in Periodontitis Patients With and Without Diabetes
- (2009) Simone Domenico Aspriello et al. JOURNAL OF PERIODONTOLOGY
- Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone
- (2009) C. Christodoulou et al. ONCOLOGY
- Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis
- (2008) M. E. Sarasquete et al. BLOOD
- Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw
- (2008) N. Raje et al. CLINICAL CANCER RESEARCH
- Degenerative periodontal-diseases and oral osteonecrosis: The role of gene-environment interactions
- (2008) D. Baldi et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now